Diabetomics is a global medical diagnostics company specializing in non-invasive point-of-care tests for diabetes and pregnancy-related conditions. Their product lineup includes Lumella® for early detection of preeclampsia and gestational diabetes, Glucema® for diabetes monitoring through saliva testing, and Insudex® for early detection of type-1 diabetes and Latent Autoimmune Diabetes in Adults (LADA). These innovative tests aim to provide quick and easy diagnostic solutions for patients and healthcare providers.
The company's focus on non-invasive testing methods represents a significant advancement in diabetes risk management and monitoring. By offering comprehensive blood analyses from a simple finger prick, Diabetomics enables patients with various types of diabetes to effectively manage their blood sugar levels. Their point-of-care solutions contribute to early detection and improved management of diabetes and related conditions, potentially alleviating the burden on patients and healthcare systems.
